About this trial
The purpose of the study is to test the effectiveness (how well the drug works), safety, and tolerability of the investigational drug called NKTR-214, when combined with nivolumab versus nivolumab given alone in participants with previously untreated melanoma skin cancer that is either unable to be surgically removed or has spread.
Where’s this trial being run?
Cork University Hospital and St Vincents University Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.Print this page
For more detailed informationClick Here
Here’s a list of questions you may have for your doctor or local cancer research team.Questions
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
|Principal Investigator:||Prof. John Crown|
Bristol Myers Squibb (BMS)
Global: November 2018
Ireland: January 2020
|Global Recruitment Target:|
|Ireland Recruitment Target:||20|